SecurityHYH / Halyard Health, Inc.
InstitutionCantab Capital Partners LLP
Shares5,332
Value $ 240,000,000
Related AVNS / Avanos Medical, Inc.
HYH.WI / Halyard Health, Inc.

Cantab Capital Partners LLP ownership in HYH / Halyard Health, Inc.

November 14, 2017 - Cantab Capital Partners LLP has filed a 13F-HR form disclosing ownership of 5,332 shares of Halyard Health, Inc. (NYSE:HYH) with total holdings valued at $240,000,000 USD as of September 30, 2017. Cantab Capital Partners LLP had filed a previous 13F-HR on May 15, 2017 disclosing 0 shares of Halyard Health, Inc. at a value of $0 USD.

Halyard Health, Inc. has declared a standard industrial code (sic) of 3842 which is the "Orthopedic, Prosthetic, and Surgical Appliances and Supplies" industry. Cantab Capital Partners LLP's top industries are "Pipelines, Except Natural Gas" (sic 46), "Oil And Gas Extraction" (sic 13), and "Automotive Repair, Services, And Parking" (sic 75).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-09-30 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 5,332 240,000
2017-03-31 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 0 -100.00 0 -100.00
2016-12-31 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 35,791.62 13,909 -12.11 514,000 -6.20 -68,577 34,577 6.31
2016-09-30 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 15,825 0.00 548,000
2015-12-31 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 0 -100.00 0 -100.00
2015-09-30 13F-HR HALYARD HEALTH, INC. CMN COM 40650V100 998 28,000

Related SEC Filings

HYH / Halyard Health, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) Halyard Health, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 40650V100 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HYH / Halyard Health, Inc. / PRICE T ROWE ASSOCIATES INC /MD/ - 3G/A (Passive Investment)

2018-02-14 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) Halyard Health, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 40650V100 (CUSIP NUMBER) December 31, 2017 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1.

HYH / Halyard Health, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
halyardhealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  Halyard Health Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  40650V100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rul

HYH / Halyard Health, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
halyardhealthinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 3 )*       Name of issuer:  Halyard Health Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  40650V100     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rul

HYH / Halyard Health, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G (Passive Investment)

2018-02-09 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No.   )*       HALYARD HEALTH INC (Name of Issuer)   Common Stock (Title of Class of Securities)     40650V100                                 (CUSIP Number)                                   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule

Related News Stories

Owens & Minor: Fade The Bounce

2018-08-27 seekingalpha
Recent acquisitions do appear to be performing well, but the core business continues a decline that's lasted pretty much this entire decade. (5-1)

Owens & Minor: Equity Investors Say "Yeah", Creditors Say "Yikes!"

2018-08-20 seekingalpha
Owens & Minor has a dividend yield of 7% and has increased its dividend for 20 consecutive years. (6-0)

Buy Our Top-Ranked Dividend Stock For 25%+ Annual Returns

2018-08-15 seekingalpha
Owens & Minor has significantly underperformed in the past year, as the company struggles within an industry downturn.

WellCare Scales 52-Week High: Can it Sustain the Bull Run?

2018-05-31 zacks
On May 30, 2018, shares of WellCare Health Plans, Inc. (WCG - Free Report) hit a 52 week high of $232.04, eventually closing the session at $227.12. The upside in share price can be attributed to a number of positive developments. (16-0)



CUSIP: 40650V100